System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Published Erratum Ahead of print

PubMed: 42907530 DOI: 10.1038/s41591-026-04747-2

Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.

Nat Med

Authors: Martina L Porter, Antonio Martorell, Christopher J Sayed, Falk G Bechara, Hadar Lev-Tov, Jennifer L Hsiao, John W Frew, Ziad Reguiaï, Melinda J Gooderham, Noah Goldfarb, Hessel H van der Zee, Veronique Del Marmol, Angelo V Marzano, Benjamin D Ehst, Lindsay S Ackerman, Koremasa Hayama, Chenwei Tian, Jennifer Kelley, Huiling Zhen, Joslyn S Kirby, Kurt Brown, Leandro L Santos, Christos C Zouboulis

Affiliations

  • Department of Dermatology, Harvard Medical School, Boston, MA, USA.
  • Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Inflammatory Diseases Unit, Department of Dermatology, Venereology and Surgery, Hospital de Manises, Valencia, Spain.
  • Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • ICH - International Center for Hidradenitis Suppurativa/Acne Inversa, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.
  • Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, FL, USA.
  • Department of Dermatology, University of Southern California, Los Angeles, CA, USA.
  • Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
  • Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia.
  • School of Clinical Medicine, University of New South Wales Sydney, Kensington, New South Wales, Australia.
  • Department of Dermatology, Polyclinique Courlancy-Bezannes, Reims-Bezannes, France.
  • Probity Medical Research, Waterloo, Ontario, Canada.
  • SKiN Centre for Dermatology, Peterborough, Ontario, Canada.
  • Queen's University, Kingston, Ontario, Canada.
  • Departments of Dermatology and Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Department of Dermatology, University of Minnesota Physicians, Minneapolis, MN, USA.
  • Department of Dermatology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Oregon Medical Research Center, Portland, OR, USA.
  • USA Medical Dermatology Specialists, US Dermatology Partners, Phoenix, AZ, USA.
  • Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Itabashi City, Tokyo, Japan.
  • Incyte Corporation, Wilmington, DE, USA.
  • Department of Dermatology, Venereology, and Immunology, Universitaetsklinikum Ruppin-Brandenburg, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Neuruppin, Germany.

MeSH

Hidradenitis Suppurativa, Hidradenitis